Rosenkranz, S.
Kramer, T.
Gerhardt, F.
Opitz, C.
Olsson, K. M.
Hoeper, M. M.
Article History
First Online: 17 July 2019
Compliance with ethical guidelines
:
: S. Rosenkranz: Remunerations for lectures and/or consultancy from Abbott, Actelion, Arena, Bayer, Ferrer, GSK, MSD, Novartis, Pfizer, and United Therapeutics. Research support to institution from Actelion, Bayer, Novartis, Pfizer, and United Therapeutics. T. Kramer: Remunerations for lectures from Actelion, Bayer, MSD. F. Gerhardt: Remunerations for lectures from Actelion, Bayer, GSK, MSD, and United Therapeutics; grants to institution from Actelion, Bayer, Novartis und United Therapeutics. C. Opitz: No personal fees as potential conflicts of interest. K.M. Olsson: Remunerations for lectures and/or consultancy from Actelion, Bayer, GSK, Pfizer und United Therapeutics. M.M. Hoeper: Honoraria for lectures and/or consulting from Actelion, Bayer, Gilead, GSK, Merck, and Pfizer.
: For this article no studies with human participants or animals were performed by any of the authors.